Article
Blood transcriptomics identifies FEZ1 as a novel non-invasive diagnostic biomarker for inflammatory bowel disease
2024-10-28
Abstract excerpt
<title>Abstract</title> <p>In comparison with conventional diagnostic methods, blood biomarkers are an easily accessible source for diagnosing inflammatory bowel disease (IBD). To identify such a biomarker, an integrated transcriptomics approach was employed to detect RNAs exhibiting diagnostic efficacy. For this purpose, four gene expression datasets obtained from blood specimens were integrated (GSE119600, GSE9...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 99a50826-1523-5654-9152-3a33b38c0d1c
- DOI
- 10.21203/rs.3.rs-5255906/v1
